Let’s Get to the Point.
Unstructured data sets, integrating data from multiple sources and working collaboratively with other departments and organisations to use real world evidence to innovate our drug discovery are the challenges that headline pharma’s priority list.
This February, industry leaders from key pharma companies like Janssen, AstraZeneca & GSKJanssen, AstraZeneca & GSK will be challenging the hype around big data. Big Pharma, Academia and SMEs alike will be drilling down to the real opportunities for pharma to exploit in order to maximise data use and develop innovative drugs
Download Last years Agenda to see what you missed